GlaxoSmithKline and Sanofi have both signed for a pharma alliances to work with the Bill & Melinda Gates Foundation.
The pharma alliance is to develop new vaccine technologies under a newly devised Vaccine Discovery Partnership.
Glaxo will join the foundation in fronting $1.8 million for work on the thermostability of vaccines.
Sanofi Pasteur will work on an effort aimed at speeding up the development of new vaccines for emerging countries.
For further deal information visit Current Agreements (subscription required)
Report: Partnering Deals and Alliances with GlaxoSmithKline
Report: Partnering Deals and Alliances with Sanofi
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity